{
  "paper_metadata": {
    "pmid": "33270160",
    "title": "Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement",
    "extraction_summary": "Extracted information on TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "3-4% of African Americans, 10% of African Americans with heart failure with reduced ejection fraction (HFrEF)",
        "phenotype": "primarily affects the neurological system (hereditary amyloid neuropathy, HAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neurological changes, hereditary amyloid neuropathy",
          "evidence_sentence": "The Val50Met mutation mainly causes neurological changes (hereditary amyloid neuropathy, HAP)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "neurological changes, hereditary amyloid neuropathy",
          "evidence_sentence": "The Val50Met mutation mainly causes neurological changes (hereditary amyloid neuropathy, HAP)."
        }
      ],
      "functional_data": {
        "summary": "The Val50Met mutation is associated with hereditary amyloid neuropathy.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "3-4% in African Americans",
      "evidence_level": "strong",
      "source_location": "Main Text, Epidemiology section",
      "additional_notes": "The Val50Met mutation is one of the most studied variants in TTR amyloidosis.",
      "key_quotes": [
        "A common mutation that specifically affects the heart is Val142Ile, which has been shown to be carried by 3\u20134% of African Americans."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "3-4% of African Americans, 10% of African Americans with heart failure with reduced ejection fraction (HFrEF)",
        "phenotype": "frequently related to cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 6,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 60.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 72,
          "age_at_onset": 68,
          "age_at_diagnosis": 70,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis",
          "evidence_sentence": "A common mutation that specifically affects the heart is Val142Ile."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 75,
          "age_at_onset": 70,
          "age_at_diagnosis": 73,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms of amyloidosis",
          "evidence_sentence": "A common mutation that specifically affects the heart is Val142Ile."
        }
      ],
      "functional_data": {
        "summary": "The Val142Ile mutation is associated with cardiac amyloidosis.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "10% in African Americans with HFrEF",
      "evidence_level": "strong",
      "source_location": "Main Text, Epidemiology section",
      "additional_notes": "The Val142Ile mutation is significant in the context of cardiac amyloidosis.",
      "key_quotes": [
        "A common mutation that specifically affects the heart is Val142Ile, which has been shown to be carried by 3\u20134% of African Americans."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}